Learn more

GENE THERAPY SYSTEMS INC

Overview
  • Total Patents
    35
  • GoodIP Patent Rank
    196,553
  • Filing trend
    0.0%
About

GENE THERAPY SYSTEMS INC has a total of 35 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INSTITUT KHIM BIOLOGII I FUNDAMENTALNOJ ME, MGVS LTD and HANGZHOU RONGZE BIOLOGICAL TECH CO LTD.

Patent filings per year

Chart showing GENE THERAPY SYSTEMS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Felgner Philip L 23
#2 Zelphati Olivier 6
#3 Liang Xiaowu 6
#4 Gao Xiang 6
#5 Ling Jing 6
#6 Roth David 5
#7 He Huaping 5
#8 Jurak Steven J 5
#9 Sorge Sr Anthony M 5
#10 Greener Alan 5

Latest patents

Publication Filing date Title
US2017072082A1 System and methods for sterilizing enclosed spaces using ozone
US2014193296A1 Apparatus and methods for ozone generation and degradation
US2011045524A1 Transfection ready eukaryotic cells
WO2007108829A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
WO2006091892A2 Methods of producing recombinant proteins
WO2006060484A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
WO2006073627A2 Vaccinia virus nucleic acids, polypeptides, and immunogenic compositions
WO2006060557A2 Protein arrays and methods and systems for producing the same
AU2003228835A1 Intracellular protein delivery compositions and methods of use
US6936470B2 Rapid and enzymeless cloning of nucleic acid fragments
WO0143778A1 Use of cationic lipids for intracellular protein delivery
AU4032300A Method for generating transcriptionally active dna fragments
EP1133465A1 Amphiphilic polyamine compounds
EP1014790A1 Chemical modification of dna using peptide nucleic acid conjugates